Malek Kechrid

814 total citations
9 papers, 712 citations indexed

About

Malek Kechrid is a scholar working on Pathology and Forensic Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Malek Kechrid has authored 9 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pathology and Forensic Medicine, 3 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Malek Kechrid's work include Chemotherapy-induced organ toxicity mitigation (4 papers), Organ Transplantation Techniques and Outcomes (3 papers) and Liver Disease and Transplantation (3 papers). Malek Kechrid is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (4 papers), Organ Transplantation Techniques and Outcomes (3 papers) and Liver Disease and Transplantation (3 papers). Malek Kechrid collaborates with scholars based in United States, Hungary and Switzerland. Malek Kechrid's co-authors include Béla Horváth, Partha Mukhopadhyay, Pál Pacher, Galin Tanchian, Eileen Holovac, Mohanraj Rajesh, Lucas Liaudet, Sándor Bátkai, Zsuzsanna K. Zsengellér and Joy Joseph and has published in prestigious journals such as Diabetes, The FASEB Journal and Free Radical Biology and Medicine.

In The Last Decade

Malek Kechrid

9 papers receiving 702 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Malek Kechrid United States 5 232 208 167 97 82 9 712
Galin Tanchian United States 7 251 1.1× 224 1.1× 310 1.9× 108 1.1× 89 1.1× 10 820
Eileen Holovac United States 6 268 1.2× 189 0.9× 274 1.6× 128 1.3× 141 1.7× 10 872
Rehab Ahmed Rifaai Egypt 17 268 1.2× 144 0.7× 86 0.5× 113 1.2× 144 1.8× 48 909
Melek Öztürk Türkiye 16 218 0.9× 187 0.9× 44 0.3× 77 0.8× 125 1.5× 49 816
Asko Riutta Finland 19 166 0.7× 80 0.4× 114 0.7× 115 1.2× 64 0.8× 52 884
Entesar F. Amin Egypt 13 155 0.7× 111 0.5× 60 0.4× 73 0.8× 120 1.5× 15 583
Ivan Srejović Serbia 16 242 1.0× 154 0.7× 59 0.4× 76 0.8× 130 1.6× 110 1.0k
Fereshteh Golab Iran 16 251 1.1× 96 0.5× 72 0.4× 82 0.8× 49 0.6× 45 795
Hongyin Du China 19 265 1.1× 94 0.5× 128 0.8× 134 1.4× 65 0.8× 46 947
Maha A. Alamin Saudi Arabia 16 218 0.9× 68 0.3× 61 0.4× 73 0.8× 160 2.0× 30 709

Countries citing papers authored by Malek Kechrid

Since Specialization
Citations

This map shows the geographic impact of Malek Kechrid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malek Kechrid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malek Kechrid more than expected).

Fields of papers citing papers by Malek Kechrid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malek Kechrid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malek Kechrid. The network helps show where Malek Kechrid may publish in the future.

Co-authorship network of co-authors of Malek Kechrid

This figure shows the co-authorship network connecting the top 25 collaborators of Malek Kechrid. A scholar is included among the top collaborators of Malek Kechrid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malek Kechrid. Malek Kechrid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
2.
Rajesh, Mohanraj, Sándor Bátkai, Malek Kechrid, et al.. (2012). Cannabinoid 1 Receptor Promotes Cardiac Dysfunction, Oxidative Stress, Inflammation, and Fibrosis in Diabetic Cardiomyopathy. Diabetes. 61(3). 716–727. 217 indexed citations
3.
Horváth, Béla, Partha Mukhopadhyay, Malek Kechrid, et al.. (2012). β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner. Free Radical Biology and Medicine. 52(8). 1325–1333. 112 indexed citations
4.
Mukhopadhyay, Partha, Béla Horváth, Zsuzsanna K. Zsengellér, et al.. (2012). Mitochondrial reactive oxygen species generation triggers inflammatory response and tissue injury associated with hepatic ischemia–reperfusion: Therapeutic potential of mitochondrially targeted antioxidants. Free Radical Biology and Medicine. 53(5). 1123–1138. 116 indexed citations
5.
Mukhopadhyay, Partha, Béla Horváth, Zsuzsanna K. Zsengellér, et al.. (2012). Mitochondrially Targeted Antioxidants Ameliorate Inflammatory Response and Tissue Injury Associated with Hepatic Ischemia-Reperfusion in Mice. Free Radical Biology and Medicine. 53. S113–S113. 4 indexed citations
6.
Mukhopadhyay, Partha, Béla Horváth, Malek Kechrid, et al.. (2011). Poly(ADP-ribose) polymerase-1 is a key mediator of cisplatin-induced kidney inflammation and injury. Free Radical Biology and Medicine. 51(9). 1774–1788. 81 indexed citations
7.
Mukhopadhyay, Partha, Béla Horváth, Malek Kechrid, et al.. (2011). Poly(ADP-ribose)Polymerase-1 is a Key Mediator of Cisplatin-Induced Kidney Inflammation And. Free Radical Biology and Medicine. 51. S93–S93. 1 indexed citations
8.
Mukhopadhyay, Partha, Béla Horváth, Zsuzsanna K. Zsengellér, et al.. (2011). Mitochondrial-targeted antioxidants represent a promising approach for prevention of cisplatin-induced nephropathy. Free Radical Biology and Medicine. 52(2). 497–506. 178 indexed citations
9.
Mukhopadhyay, Partha, Béla Horváth, Zsuzsanna K. Zsengellér, et al.. (2011). Mitochondrial-Targeted Antioxidants Represent a Promising Approach for Prevention Of. Free Radical Biology and Medicine. 51. S93–S93. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026